NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Purple Biotech Ltd (TA: PPBT)

 
PPBT Technical Analysis
5
As on 21st Nov 2024 PPBT STOCK Price closed @ 4.90 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 41.22 & Strong Sell for SHORT-TERM with Stoploss of 56.43 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PPBTSTOCK Price

Open 5.00 Change Price %
High 5.00 1 Day -0.30 -5.77
Low 4.80 1 Week -0.40 -7.55
Close 4.90 1 Month -5.20 -51.49
Volume 295600 1 Year -62.50 -92.73
52 Week High 70.00 | 52 Week Low 4.70
 
TA Israel Most Active Stocks
TA125 2008.05 1.06%
ORL 92.30 -5.04%
BLRX 10.50 -25.00%
CANF 2.60 -3.70%
BEZQ 520.00 -2.71%
ELAL 846.50 1.46%
LUMI 4135.00 1.67%
ICL 1689.00 2.80%
POLI 4210.00 2.13%
DSCT 2394.00 1.79%
 
TA Israel Top Gainers Stocks
SEFA 520.00 25.30%
SEFA 520.00 25.30%
NALA 520.00 25.30%
TDGN-L 171.50 17.55%
TEFN 75.00 15.03%
TEFN 75.00 15.03%
INTL 75.00 15.03%
INTL 75.00 15.03%
CNMD 45.10 10.54%
CNMD 45.10 10.54%
 
TA Israel Top Losers Stocks
BLRX 10.50 -25.00%
BLRX 10.50 -25.00%
KMNK 51.00 -23.19%
ULTR 74.10 -16.74%
EMTC 20.00 -14.16%
BTX 230.00 -12.65%
BTX 230.00 -12.65%
BTX 230.00 -12.65%
BTX 230.00 -12.65%
BTX 230.00 -12.65%
 
 
PPBT
Daily Charts
PPBT
Intraday Charts
Whats New @
Bazaartrend
PPBT
Free Analysis
 
PPBT Important Levels Intraday
RESISTANCE5.29
RESISTANCE5.16
RESISTANCE5.09
RESISTANCE5.01
SUPPORT4.79
SUPPORT4.71
SUPPORT4.64
SUPPORT4.51
 
PPBT Forecast November 2024
4th UP Forecast50.76
3rd UP Forecast36.05
2nd UP Forecast26.96
1st UP Forecast17.87
1st DOWN Forecast-8.07
2nd DOWN Forecast-17.16
3rd DOWN Forecast-26.25
4th DOWN Forecast-40.96
 
PPBT Weekly Forecast
4th UP Forecast18.39
3rd UP Forecast14.06
2nd UP Forecast11.39
1st UP Forecast8.72
1st DOWN Forecast1.09
2nd DOWN Forecast-1.59
3rd DOWN Forecast-4.26
4th DOWN Forecast-8.59
 
PPBT Forecast2024
4th UP Forecast130.73
3rd UP Forecast90.38
2nd UP Forecast65.43
1st UP Forecast40.49
1st DOWN Forecast-30.69
2nd DOWN Forecast-55.63
3rd DOWN Forecast-80.58
4th DOWN Forecast-120.93
 
 
PPBT Other Details
Segment EQ
Market Capital 24996818944.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
PPBT Address
PPBT
 
PPBT Latest News
 
Your Comments and Response on Purple Biotech Ltd
 
PPBT Business Profile
Purple Biotech Ltd. is a clinical-stage company focused on advancing therapies to overcome tumor immune evasion and drug resistance to create treatments for cancer patients in the United States. It operates through two segments, Oncology, and Pain and Hypertension. The company's marketed products include Consensi, a fixed-dose combination of celecoxib and amlodipine besylate for the simultaneous treatment of osteoarthritis pain and hypertension. Its oncology pipeline includes NT219, a small molecule that targets insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment of recurrent and/or metastatic solid tumors and squamous cell carcinoma of the head and neck cancer; and CM24, a monoclonal antibody blocking CEACAM1 that is being developed as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. Purple Biotech Ltd. was founded in 2010 and is headquartered in Rehovot, Israel. Address: 4 Oppenheimer Street, Rehovot, Israel, 7670104
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service